-
2023Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma., Front Oncol 2023 ; 13(): 1110916.
-
2022The Sec61 translocon is a therapeutic vulnerability in multiple myeloma., EMBO Mol Med 2022 03; 14(3): e14740.
-
2018Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells., Nat Commun. 2018 Jun 8;9(1):2241.
-
2018Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling., Cancer Res. 2018 Jun 1;78(11):3014-3026.
-
2016B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer, Int. J. Cancer 2016 Sep;139(6):1358-71.
-
2014Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses, J. Immunol. 2014 Aug;193(4):1787-98.
-
2012Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice, Blood 2012 Jul;120(1):90-9.
-
2008Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation, Blood 2008 Nov;112(9):3713-22.
-
2008Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population, J. Immunol. 2008 May;180(10):6760-7.
-
2006Purification of splenic dendritic cells induces maturation and capacity to stimulate Th1 response in vivo, Int. Immunol. 2006 Mar;18(3):445-52.
-
2004Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation, Blood 2004 Sep;104(6):1808-15.
-
2004New tools for antigen delivery to the MHC class I pathway, Trends Immunol. 2004 Feb;25(2):92-7.
-
2003Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes, Int. Immunol. 2003 Dec;15(12):1423-30.
-
2002Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells, J. Immunol. 2002 Mar;168(5):2219-24.
-
1997Potential deleterious effect of anti-viral cytotoxic lymphocyte through the CD95 (FAS/APO-1)-mediated pathway during chronic HIV infection, Immunol. Lett. 1997 Jun;57(1-3):53-8.
-
1997Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells, Blood 1997 Jan;89(1):329-36.
-
1996Evidence for an in vivo superantigenic activity in human immunodeficiency virus-infected individuals, Blood 1996 Sep;88(6):2151-61.
-
1994Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals, J. Exp. Med. 1994 Feb;179(2):413-24.
-
1993Is a dominant superantigen involved in AIDS pathogenesis?, Lancet 1993 Jul;342(8862):50-1.